Inspire Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-29,411
Closed -$2.74M 730
2026
Q1
$2.74M Buy
+29,411
New +$2.6M 0.22% 77
2024
Q2
Sell
-5,807
Closed -$648K 380
2024
Q1
$648K Buy
5,807
+2,636
+83% +$314K 0.09% 152
2023
Q4
$411K Buy
+3,171
New +$437K 0.06% 216
2023
Q1
Sell
-11,231
Closed -$891K 204
2022
Q4
$891K Buy
+11,231
New +$791K 0.22% 21
2022
Q3
Sell
-4,975
Closed -$273K 158
2022
Q2
$273K Buy
+4,975
New +$288K 0.08% 53

Other funds holding ACLS

Inspire Advisors's ACLS Position: Q2 2026 in Review

Inspire Advisors sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 29,411 shares — an estimated $2.74M sold.

Inspire Advisors first reported a position in ACLS in Q2 2022 and held it in 5 quarters. The position peaked at $2.74M in Q1 2026. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Inspire Advisors reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Inspire Advisors sold 29,411 Axcelis shares in Q2 2026, an estimated $2.74M.
  • Inspire Advisors first reported a position in Axcelis in Q2 2022 and held it in 5 quarters.
  • Inspire Advisors's Axcelis position peaked at $2.74M in Q1 2026.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.